Industry: Service & Software
Published Date: 2025-06-18
Pages: 84 Pages
Report ld: 4767422
Request Sample
Customized Report
Pharmaceutical Decommissioning Service Market Size(US$)

CAGR 2025-2031
5.6%
Market Size,2031
USD 1,114
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical Decommissioning Service was valued at US$ 785 million in the year 2024 and is projected to reach a revised size of US$ 1114 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Pharmaceutical Decommissioning Service is a one-stop professional service from assessment, planning, demolition, disposal to site restoration and reuse for production facilities, equipment, plants and related systems that are decommissioned by pharmaceutical companies due to equipment aging, technology upgrades, regulatory requirements or corporate strategy adjustments. It covers equipment compliance inspection, hazardous substance treatment, waste environmental recycling, safe demolition of building structures and site ecological restoration, ensuring that the decommissioning process complies with the Good Manufacturing Practice (GMP) for pharmaceuticals, environmental protection regulations and safety production standards. At the same time, through resource recycling and site function reconstruction, it helps companies achieve sustainable development goals.
North American market for Pharmaceutical Decommissioning Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Decommissioning Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pharmaceutical Decommissioning Service in Pharmaceutical Manufacturers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pharmaceutical Decommissioning Service include KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, Qualitech Environmental Services, Hughes & Salvidge, Divestiture, Pharmagraph, RVA Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Decommissioning Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Decommissioning Service.
The Pharmaceutical Decommissioning Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Decommissioning Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Decommissioning Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Decommissioning Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Decommissioning Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Equipment Decommissioning Service
1.2.3 Facility Decommissioning Service
1.2.4 Laboratory Decommissioning Service
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Decommissioning Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Manufacturers
1.3.3 Pharmaceutical CDMO
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Decommissioning Service Market Perspective (2020-2031)
2.2 Global Pharmaceutical Decommissioning Service Growth Trends by Region
2.2.1 Global Pharmaceutical Decommissioning Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Decommissioning Service Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Decommissioning Service Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Decommissioning Service Market Dynamics
2.3.1 Pharmaceutical Decommissioning Service Industry Trends
2.3.2 Pharmaceutical Decommissioning Service Market Drivers
2.3.3 Pharmaceutical Decommissioning Service Market Challenges
2.3.4 Pharmaceutical Decommissioning Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Decommissioning Service Players by Revenue
3.1.1 Global Top Pharmaceutical Decommissioning Service Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Decommissioning Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Pharmaceutical Decommissioning Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Decommissioning Service Revenue
3.4 Global Pharmaceutical Decommissioning Service Market Concentration Ratio
3.4.1 Global Pharmaceutical Decommissioning Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Decommissioning Service Revenue in 2024
3.5 Global Key Players of Pharmaceutical Decommissioning Service Head office and Area Served
3.6 Global Key Players of Pharmaceutical Decommissioning Service, Product and Application
3.7 Global Key Players of Pharmaceutical Decommissioning Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Decommissioning Service Breakdown Data by Type
4.1 Global Pharmaceutical Decommissioning Service Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Decommissioning Service Breakdown Data by Application
5.1 Global Pharmaceutical Decommissioning Service Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Decommissioning Service Market Size (2020-2031)
6.2 North America Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Decommissioning Service Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Decommissioning Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Decommissioning Service Market Size (2020-2031)
7.2 Europe Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Decommissioning Service Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Decommissioning Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Decommissioning Service Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Decommissioning Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Decommissioning Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Decommissioning Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharmaceutical Decommissioning Service Market Size (2020-2031)
9.2 Latin America Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Decommissioning Service Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Decommissioning Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Decommissioning Service Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KDC Veolia
11.1.1 KDC Veolia Company Details
11.1.2 KDC Veolia Business Overview
11.1.3 KDC Veolia Pharmaceutical Decommissioning Service Introduction
11.1.4 KDC Veolia Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.1.5 KDC Veolia Recent Development
11.2 RCS Pharma
11.2.1 RCS Pharma Company Details
11.2.2 RCS Pharma Business Overview
11.2.3 RCS Pharma Pharmaceutical Decommissioning Service Introduction
11.2.4 RCS Pharma Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.2.5 RCS Pharma Recent Development
11.3 Technical Safety Services
11.3.1 Technical Safety Services Company Details
11.3.2 Technical Safety Services Business Overview
11.3.3 Technical Safety Services Pharmaceutical Decommissioning Service Introduction
11.3.4 Technical Safety Services Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.3.5 Technical Safety Services Recent Development
11.4 ISPE
11.4.1 ISPE Company Details
11.4.2 ISPE Business Overview
11.4.3 ISPE Pharmaceutical Decommissioning Service Introduction
11.4.4 ISPE Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.4.5 ISPE Recent Development
11.5 Brilliant Equipment Services
11.5.1 Brilliant Equipment Services Company Details
11.5.2 Brilliant Equipment Services Business Overview
11.5.3 Brilliant Equipment Services Pharmaceutical Decommissioning Service Introduction
11.5.4 Brilliant Equipment Services Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.5.5 Brilliant Equipment Services Recent Development
11.6 Qualitech Environmental Services
11.6.1 Qualitech Environmental Services Company Details
11.6.2 Qualitech Environmental Services Business Overview
11.6.3 Qualitech Environmental Services Pharmaceutical Decommissioning Service Introduction
11.6.4 Qualitech Environmental Services Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.6.5 Qualitech Environmental Services Recent Development
11.7 Hughes & Salvidge
11.7.1 Hughes & Salvidge Company Details
11.7.2 Hughes & Salvidge Business Overview
11.7.3 Hughes & Salvidge Pharmaceutical Decommissioning Service Introduction
11.7.4 Hughes & Salvidge Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.7.5 Hughes & Salvidge Recent Development
11.8 Divestiture
11.8.1 Divestiture Company Details
11.8.2 Divestiture Business Overview
11.8.3 Divestiture Pharmaceutical Decommissioning Service Introduction
11.8.4 Divestiture Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.8.5 Divestiture Recent Development
11.9 Pharmagraph
11.9.1 Pharmagraph Company Details
11.9.2 Pharmagraph Business Overview
11.9.3 Pharmagraph Pharmaceutical Decommissioning Service Introduction
11.9.4 Pharmagraph Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.9.5 Pharmagraph Recent Development
11.10 RVA Group
11.10.1 RVA Group Company Details
11.10.2 RVA Group Business Overview
11.10.3 RVA Group Pharmaceutical Decommissioning Service Introduction
11.10.4 RVA Group Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.10.5 RVA Group Recent Development
11.11 DSM Demolition
11.11.1 DSM Demolition Company Details
11.11.2 DSM Demolition Business Overview
11.11.3 DSM Demolition Pharmaceutical Decommissioning Service Introduction
11.11.4 DSM Demolition Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.11.5 DSM Demolition Recent Development
11.12 KERAMIDA Inc
11.12.1 KERAMIDA Inc Company Details
11.12.2 KERAMIDA Inc Business Overview
11.12.3 KERAMIDA Inc Pharmaceutical Decommissioning Service Introduction
11.12.4 KERAMIDA Inc Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.12.5 KERAMIDA Inc Recent Development
11.13 Downwell Enabling Solutions
11.13.1 Downwell Enabling Solutions Company Details
11.13.2 Downwell Enabling Solutions Business Overview
11.13.3 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Introduction
11.13.4 Downwell Enabling Solutions Revenue in Pharmaceutical Decommissioning Service Business (2020-2025)
11.13.5 Downwell Enabling Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1170 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 143
USD 4900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market size was US$ 803 million in 2025 and is forecast to reach a readjusted size of US$ 1170 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 93
USD 4250.00
(Single User License)
The global Pharmaceutical Decommissioning Service market was valued at US$ 803 million in 2025 and is anticipated to reach US$ 1170 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 114
USD 2900.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 803 million in 2025 and is projected to reach US$ 1170 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 106
USD 3950.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-06-18
Pages: 119
USD 3950.00
(Single User License)
The global Pharmaceutical Decommissioning Service market size was US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-06-18
Pages: 93
USD 4250.00
(Single User License)
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1114 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published Date: 2025-06-18
Pages: 145
USD 4900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1170 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 143
The global Pharmaceutical Decommissioning Service market size was US$ 803 million in 2025 and is forecast to reach a readjusted size of US$ 1170 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 93
The global Pharmaceutical Decommissioning Service market was valued at US$ 803 million in 2025 and is anticipated to reach US$ 1170 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 114
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 803 million in 2025 and is projected to reach US$ 1170 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 106
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-06-18
Pages: 119
The global Pharmaceutical Decommissioning Service market size was US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-06-18
Pages: 93
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1114 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published: 2025-06-18
Pages: 145
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now